Abits
ABTS
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
CATHEDRA BITCOIN INC
CBTTF
US Stock MarketDetailed Quotes
GBIO Generation Bio
- 1.160
- -0.030-2.52%
Close Dec 13 16:00 ET
- 1.210
- +0.050+4.27%
Post 20:01 ET
77.48MMarket Cap-0.53P/E (TTM)
1.300High1.110Low469.84KVolume1.220Open1.190Pre Close546.96KTurnover0.96%Turnover RatioLossP/E (Static)66.79MShares4.65052wk High0.74P/B56.63MFloat Cap1.11052wk Low--Dividend TTM48.82MShs Float55.720Historical High--Div YieldTTM15.97%Amplitude0.860Historical Low1.164Avg Price1Lot Size
About Generation Bio Company
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
Company Profile
SymbolGBIO
Company NameGeneration Bio
Listing DateJun 12, 2020
Issue Price19.00
Founded2016
CEODr. Geoffrey McDonough, M.D.
MarketNASDAQ
Employees174
Fiscal Year Ends12-31
Address301 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-655-7500
Websitehttp://www.generationbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Geoffrey McDonough, M.D.
- President, Chief Executive Officer and Director
- 2.32M
- Yalonda Howze, J.D.
- Chief Legal Officer and Secretary
- 1.21M
- Antionette Paone, M.B.A.,M.S.
- Chief Operating Officer
- --
- Matthew Stanton, PhD
- Chief Scientific Officer
- 1.15M
- Dr. Phillip Samayoa, PhD
- Chief Strategy Officer
- --
- Dr. Matthew Norkunas, M.B.A.,M.D.
- Chief Financial Officer and Principal Accounting Officer
- 1.14M
- Jason P. Rhodes
- Chairman of the Board
- 181.21K
- Dr. Donald W. Nicholson, PhD
- Independent Director
- 143.71K
- Dannielle Appelhans
- Independent Director
- 140.21K
- Gustav A. Christensen
- Independent Director
- 143.71K
- Charles A. Rowland, Jr,M.B.A.
- Independent Director
- 151.21K
- Dr. Catherine Stehman-Breen, M.D.
- Independent Director
- 143.71K
- Ronald H.W. Cooper
- Independent Director
- 144.21K
- Anthony G. Quinn, Ch.B.,M.B.,PhD
- Independent Director
- 143.71K
- Dr. Jeffrey M. Jonas,M.D.
- Independent Director
- 140.21K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.